Inovio Pharma (INO) Tops Q2 EPS by 18c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.09 --0%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
GNLN, USDP, AFIB, More
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
GNLN, USDP, AFIB, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Greenlane Holdings Inc. (GNLN) reported Q2 result
- Praxis Precision Medicines Inc. (PRAX) PT Raised to $945 at Raymond James
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
